23andMe and Ancestory.com allow people to spit in a tube and have their DNA analysed to learn more about their ancestory and any health risks. To date, more than 14 million people have spit in tubes and sent it in to 23andMe. Now the company is selling access to an anonymised database of customer DNA to pharmaceutical giant GSK.
In today's episode of The Dive, Bryce and Ren look at how genealogy companies use the customer DNA they collect, and how it has been used to do everything from discover new drugs to solve murders.
Want more Equity Mates? Click here.
In the spirit of reconciliation, Equity Mates Media and the hosts of The Dive acknowledge the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people today.
*****
This podcast is intended for education and entertainment purposes. Any advice is general advice only, and has not taken into account your personal financial circumstances, needs or objectives.
Before acting on general advice, you should consider if it is relevant to your needs and read the relevant Product Disclosure Statement. And if you are unsure, please speak to a financial professional.
Equity Mates Media operates under Australian Financial Services Licence 540697.
The Dive is part of the Acast Creator Network.
Hosted on Acast. See acast.com/privacy for more information.
More Episodes
2022-11-04
2022-11-02
2022-10-31
2022-10-28
Get this podcast on your
phone, FREE
